RIPK2 is an unfavorable prognosis marker and a potential therapeutic target in human kidney renal clear cell carcinoma.
Li D, Tang L, Liu B, Xu S, Jin M, Bo W
Aging (Albany NY). 2021 Mar 31;13(7):10450-10467. doi: 10.18632/aging.202808. Epub 2021 Mar 31.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.